Traversa Therapeutics Inc., a La Jolla, Calif.-based provider of RNAi delivery technologies, has raised $5 million in Series B funding. Morningside Venture Investments led the round, and was joined by fellow return backers Mesa Verde Venture Partners. It had previously raised $2 million.
2 min read · 03 April 2009
1 min read · 03 April 2009
CeraPedics Inc., a Lakewood, Colo.-based developer of products for the orthopedic bone substitutes market, has raised $15 million in second-round funding, according to a regulatory filing. NGN Capital was joined by return backer OrbiMed Advisors. The company previously around around $14.5 million. www.cerapedics.com
1 min read · 02 April 2009
Altea Therapeutics has signed a deal with Eli Lilly and Amylin Pharmaceuticals to develop and commercialize a daily trans-dermal patch delivering exenatide. The patch would use Alteo trans-dermal delivery technology. Under terms of the deal, Atlanta-based Altea will receive an upfront license payment, an equity investment and up to $46 million in milestone payments. Altea previously raised around $56 million in VC funding from Domain Associates, Venrock, vSpring Capital, Aperture Venture Partners, KBC Private Equity, Rockport Venture Partners and Quilvest Private Equity.
4 min read · 02 April 2009
Imprivata Inc., a Lexington, Mass.-based developer of identity management software, has acquired the assets of IdentiPHI, including its SAFsolution product line and biometric patents. Imprivata has raised over $45 million in VC funding from firms like General Catalyst Partners, Highland Capital Partners, Polaris Venture Partners and SAP Ventures.
2 min read · 01 April 2009
TubeMogul, an Emeryville, Calif.-based, has raised provider of online video distribution and analytics, has raised $3 million in Series A funding from Trinity Ventures.
4 min read · 01 April 2009
D2S (f.k.a. Direct2Silicon), a San Jose, Calif.–based provider of software that enables direct write e-beam lithography for production of system-on-a-chip ICs, has raised $9 million in Series B funding. peHUB had previously reported on the round, based on a regulatory filing. Benchmark Capital and DAG Ventures co-led the round, and were joined by Advantest Corp. and Cadence Design Systems Inc.
3 min read · 01 April 2009
RedBrick Health, a Minneapolis-based provider of personal health financing and management solutions, has raised $15 million in Series C funding. Kleiner Perkins Caufield & Byers led the round, and was joined by return backers Highland Capital Partners, Versant Ventures and Fidelity Ventures. The company had previously raised $30 million.
3 min read · 01 April 2009
LogRhythm Inc., a Boulder, Colo.-based provider of log management and analysis software, has raised just over $3.1 million in second-round funding, according to a regulatory filing. Joe Zell of Grotech Ventures is listed as a new board member, alongside reps from existing shareholders Access Venture Partners and Colorado Fund. www.logrhythm.com
1 min read · 01 April 2009
Ambrx Inc., a La Jolla, Calif.-based developer of genetically-engineered protein therapeutics, has raised $10 million in new VC funding, according to a regulatory filing. The company previously raised around $70 million from firms like 5AM Ventures, Aravis Ventures, CMEA Capital, Maverick Capital, Versant Ventures and Tavistock Life Sciences. www.ambrx.com
1 min read · 01 April 2009
